Literature DB >> 2253531

Human gastric mucosa expresses glandular M3 subtype of muscarinic receptors.

A Pfeiffer1, C Hanack, R Kopp, R Tacke, U Moser, E Mutschler, G Lambrecht, M Herawi.   

Abstract

Five subtypes of muscarinic receptors have been distinguished by pharmacological and molecular biological methods. This report characterizes the muscarinic subtype present in human gastric mucosa by radioligand binding studies. The receptor density was 27 +/- 6 fmol/mg protein and the tritiated ligand N-methylscopolamine had an affinity of (KD) 0.39 +/- 0.08 nM (n = 11). The M1 receptor selective antagonist pirenzepine and the M2 receptor selective ligand AF-DX 116 had low affinities of 148 +/- 32 nM (n = 13) and 4043 +/- 1011 nM (n = 3) KD, respectively. The glandular M3 antagonists hexahydrosiladifenidol and silahexocyclium had high affinities of KD 78 +/- 23 nM (n = 5) and 5.6 +/- 1.8 nM (n = 3). The agonist carbachol interacted with a single low-affinity site and binding was insensitive to modulation by guanine nucleotides. Antagonist and agonist binding studies thus showed an affinity profile typical of M3 receptors of the glandular type.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2253531     DOI: 10.1007/bf01540563

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  35 in total

1.  Different binding properties of muscarinic M2-receptor subtypes for agonists and antagonists in porcine gastric smooth muscle and mucosa.

Authors:  M Herawi; G Lambrecht; E Mutschler; U Moser; A Pfeiffer
Journal:  Gastroenterology       Date:  1988-03       Impact factor: 22.682

2.  Primary structure of porcine cardiac muscarinic acetylcholine receptor deduced from the cDNA sequence.

Authors:  T Kubo; A Maeda; K Sugimoto; I Akiba; A Mikami; H Takahashi; T Haga; K Haga; A Ichiyama; K Kangawa
Journal:  FEBS Lett       Date:  1986-12-15       Impact factor: 4.124

3.  The regulation of muscarinic cholinergic receptors by guanine nucleotides in cardiac tissue.

Authors:  L B Rosenberger; W R Roeske; H I Yamamura
Journal:  Eur J Pharmacol       Date:  1979-06       Impact factor: 4.432

Review 4.  Muscarinic acetylcholine receptors: structure, function subtypes and therapeutic perspectives.

Authors:  E C Hulme; N J Birdsall; M Wheatley; C Curtis; E K Pedder; D Poyner; J M Stockton; P Eveleigh
Journal:  Postgrad Med J       Date:  1987       Impact factor: 2.401

5.  Identification of a family of muscarinic acetylcholine receptor genes.

Authors:  T I Bonner; N J Buckley; A C Young; M R Brann
Journal:  Science       Date:  1987-07-31       Impact factor: 47.728

6.  Organ selectivity of hexahydrosiladifenidol in blocking pre- and postjunctional muscarinic receptors studied in guinea-pig ileum and rat heart.

Authors:  H Fuder; H Kilbinger; H Müller
Journal:  Eur J Pharmacol       Date:  1985-07-11       Impact factor: 4.432

7.  Pirenzepine distinguishes between different subclasses of muscarinic receptors.

Authors:  R Hammer; C P Berrie; N J Birdsall; A S Burgen; E C Hulme
Journal:  Nature       Date:  1980-01-03       Impact factor: 49.962

8.  Antimuscarinic action of methoctramine, a new cardioselective M-2 muscarinic receptor antagonist, alone and in combination with atropine and gallamine.

Authors:  C Melchiorre; P Angeli; G Lambrecht; E Mutschler; M T Picchio; J Wess
Journal:  Eur J Pharmacol       Date:  1987-12-01       Impact factor: 4.432

9.  Stimulation of acid secretion and phosphoinositol production by rat parietal cell muscarinic M2 receptors.

Authors:  A Pfeiffer; H Rochlitz; A Herz; G Paumgartner
Journal:  Am J Physiol       Date:  1988-04

10.  Muscarinic M2-receptors enhance polyphosphoinositol release in rat gastric mucosal cells.

Authors:  A Pfeiffer; G Paumgartner; A Herz
Journal:  FEBS Lett       Date:  1986-08-18       Impact factor: 4.124

View more
  3 in total

1.  Regulation of gastric function by endogenous gastrin releasing peptide in humans: studies with a specific gastrin releasing peptide receptor antagonist.

Authors:  P Hildebrand; F S Lehmann; S Ketterer; A D Christ; T Stingelin; J Beltinger; A H Gibbons; D H Coy; J Calam; F Larsen; C Beglinger
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

2.  Muscarinic receptors in gastric mucosa are increased in peptic ulcer disease.

Authors:  A Pfeiffer; W Krömer; J Friemann; M Ruge; M Herawi; M Schätzl; U Schwegler; B May; H Schatz
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

3.  Binding and functional properties of hexocyclium and sila-hexocyclium derivatives to muscarinic receptor subtypes.

Authors:  M Waelbroeck; J Camus; M Tastenoy; R Feifel; E Mutschler; R Tacke; C Strohmann; K Rafeiner; J F Rodrigues de Miranda; G Lambrecht
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.